Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance

Tara Cochrane*, Belinda A. Campbell, Shane A. Gangatharan, Maya Latimer, Richard Khor, David R.H. Christie, Michael Gilbertson, Sumita Ratnasingam, Emma Palfreyman, Hui Peng Lee, Judith Trotman, Mark Hertzberg, Michael Dickinson

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)
1 Downloads (Pure)

Abstract

The management of Hodgkin lymphoma (HL) has undergone significant changes in recent years. Due to the predilection of HL to affect younger patients, balancing cure and treatment-related morbidity is a constant source of concern for physicians and patients alike. Positron emission tomography adapted therapy has been developed for both early and advanced stage HL to try and improve the outcome of treatment, while minimising toxicities. The aim of this review is to digest the plethora of studies recently conducted and provide some clear, evidence-based practice statements to simplify the management of HL.

Original languageEnglish
Pages (from-to)2119-2128
Number of pages10
JournalInternal Medicine Journal
Volume51
Issue number12
DOIs
Publication statusPublished - Dec 2021

Fingerprint

Dive into the research topics of 'Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance'. Together they form a unique fingerprint.

Cite this